Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Jauregui R, Thomas AL, Liechty B, Velez G, Mahajan VB, Clark L, et al. SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A. 2019;179(2):312-316.

Conteduca V, Oromendia C, Eng KW, Bareja R, Sigouros M, Molina A, et al. Clinical features of neuroendocrine prostate cancer. Eur J Cancer. 2019;121:7-18.

Cimic A, Wilkin TJ, Heymann JJ, Alperstein S, Ellsworth G, Siddiqui MT. Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women. Cancer Cytopathol. 2019;127(6):407-413.

Ji G, Xu R, Niu Y, Li N, Ivashkiv L, Bostrom MP, et al. Vascular endothelial growth factor pathway promotes osseointegration and CD31EMCN endothelium expansion in a mouse tibial implant model: an animal study. Bone Joint J. 2019;101-B(7_Supple_C):108-114.

Hickman R, Leeman-Neill R, Rosenblum M, Anderson R, Goldman J. Co-existent pilocytic astrocytoma with acute B-cell leukemia within the cerebellum. Neuropathology. 2019;39(5):394-397.

Zhang Y, Mun SR, Linares JF, Towers CG, Thorburn A, Diaz-Meco MT, et al. Mechanistic insight into the regulation of SQSTM1/p62. Autophagy. 2019;15(4):735-737.

Makhni MC, Zhang Y, Park PJ, Cerpa M, Yang M, Pham MH, et al. The "kickstand rod" technique for correction of coronal imbalance in patients with adult spinal deformity: initial case series. J Neurosurg Spine. 2019:1-8.

Marshall CH, Imada EL, Tang Z, Marchionni L, Antonarakis ES. CDK12 inactivation across solid tumors: an actionable genetic subtype. Oncoscience. 2019;6(5-6):312-316.

Musselman K, Glynn S, Mosquera JM, Elemento O, Sboner A, Beltran H, et al. Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma. Gynecol Oncol Rep. 2019;28:54-57.

Guerrero-Preston R, Lawson F, Rodriguez-Torres S, Noordhuis MG, Pirini F, Manuel L, et al. Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients. Cancer Prev Res (Phila). 2019;12(4):255-270.